Scynexis (SCYX) Treasury Shares (2013 - 2026)
Scynexis' (SCYX) quarterly Treasury Shares came in at $3.7 million in Q1 2026, up 8.86% YoY from $3.4 million in Q1 2025, and up 40.12% on a QoQ basis from $2.7 million in Q4 2025.
Scynexis (SCYX) Treasury Shares (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 12 years of Treasury Shares data on file, last reported at $3.7 million in Q1 2026.
- Quarterly Treasury Shares rose 8.86% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 8.86% YoY) and the FY2025 annual result came in at $2.7 million, down 14.63% from the prior year.
- Treasury Shares climbed to $3.7 million in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $3.7 million in Q1 2026 to a low of $633270.0 in Q4 2022.
- A 5-year average of $2.4 million and a median of $2.7 million in 2025 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares jumped 912.48% — and 2025, when it declined 14.63%.
- Tracing SCYX's Treasury Shares over 5 years: stood at $633270.0 in 2022, then jumped by 197.88% to $1.9 million in 2023, then surged by 65.42% to $3.1 million in 2024, then fell by 14.63% to $2.7 million in 2025, then surged by 40.12% to $3.7 million in 2026.
- The last three Treasury Shares figures came in at $3.7 million (Q1 2026), $2.7 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 4.13 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 1.30 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -297.63 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 35.35 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 19.00 Mn |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 439,104.00 |
| Jun 30, 2026 | 439,104.00 |
| Mar 31, 2026 | 3.73 Mn |
| Mar 31, 2026 | 3.73 Mn |
| Dec 31, 2025 | 2.66 Mn |
| Dec 31, 2025 | 2.66 Mn |
| Sep 30, 2025 | 2.69 Mn |
| Sep 30, 2025 | 2.69 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 3.12 Mn |
| Dec 31, 2024 | 3.12 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | 3.26 Mn |
| Jun 30, 2024 | 3.26 Mn |
| Mar 31, 2024 | 3.20 Mn |
| Mar 31, 2024 | 3.20 Mn |